Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
- PMID: 20164116
- PMCID: PMC2856192
- DOI: 10.1093/cvr/cvq045
Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
Abstract
The vascular system delivers oxygen and nutrients to every cell in the vertebrate organism. Hypoxia-inducible factor 1 (HIF-1) is a master regulator of hypoxic/ischaemic vascular responses, driving transcriptional activation of hundreds of genes involved in vascular reactivity, angiogenesis, arteriogenesis, and the mobilization and homing of bone marrow-derived angiogenic cells. This review will focus on the pivotal role of HIF-1 in vascular homeostasis, the involvement of HIF-1 in vascular diseases, and recent advances in targeting HIF-1 for therapy in preclinical models.
Similar articles
-
Vascular responses to hypoxia and ischemia.Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):648-52. doi: 10.1161/ATVBAHA.108.181644. Epub 2009 Sep 3. Arterioscler Thromb Vasc Biol. 2010. PMID: 19729615 Free PMC article. Review.
-
Hypoxia-inducible factor 1 in lower limb ischemia.Vascular. 2006 Nov-Dec;14(6):321-7. doi: 10.2310/6670.2006.00056. Vascular. 2006. PMID: 17150152 Review.
-
Regulation of angiogenesis by hypoxia and hypoxia-inducible factors.Curr Top Dev Biol. 2006;76:217-57. doi: 10.1016/S0070-2153(06)76007-0. Curr Top Dev Biol. 2006. PMID: 17118268 Review.
-
Decreased vascular repair and neovascularization with ageing: mechanisms and clinical relevance with an emphasis on hypoxia-inducible factor-1.Curr Mol Med. 2008 Dec;8(8):754-67. doi: 10.2174/156652408786733685. Curr Mol Med. 2008. PMID: 19075673 Review.
-
Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia.J Mol Med (Berl). 2007 Dec;85(12):1309-15. doi: 10.1007/s00109-007-0279-x. Epub 2007 Nov 20. J Mol Med (Berl). 2007. PMID: 18026917 Review.
Cited by
-
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity.J Transl Med. 2016 May 5;14(1):119. doi: 10.1186/s12967-016-0872-2. J Transl Med. 2016. PMID: 27149858 Free PMC article.
-
Proposal of a hybrid approach for tumor progression and tumor-induced angiogenesis.Theor Biol Med Model. 2015 Jul 2;12:13. doi: 10.1186/s12976-015-0009-y. Theor Biol Med Model. 2015. PMID: 26133367 Free PMC article. Review.
-
Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization.J Investig Med. 2016 Feb;64(2):361-3. doi: 10.1097/JIM.0000000000000206. Epub 2016 Jan 11. J Investig Med. 2016. PMID: 25955799 Free PMC article. Review.
-
BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF.Angiogenesis. 2021 Feb;24(1):129-144. doi: 10.1007/s10456-020-09748-4. Epub 2020 Oct 6. Angiogenesis. 2021. PMID: 33021694 Free PMC article.
-
Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers.J Clin Invest. 2019 Feb 1;129(2):442-451. doi: 10.1172/JCI120855. Epub 2019 Jan 7. J Clin Invest. 2019. PMID: 30614813 Free PMC article. Review.
References
-
- Dioum EM, Clarke SL, Ding K, Repa JJ, Garcia JA. HIF-2α-haploinsufficient mice have blunted retinal neovascularization due to impaired expression of a proangiogenic gene battery. Invest Ophthalmol Vis Sci. 2008;49:2714–2720. - PubMed
-
- Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 1997;11:72–82. - PubMed
-
- Kaelin WG, Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393–402. - PubMed
-
- Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-α to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468–472. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources